Full Text View
Tabular View
No Study Results Posted
Related Studies
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
This study is ongoing, but not recruiting participants.
Study NCT01353625   Information provided by Celgene Corporation

First Received on May 12, 2011.   Last Updated on November 9, 2015   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial